U.S. pharma huge copyright scrapped two experimental weight loss supplements previous 12 months—a at the time-each day pill, lotiglipron, on account of elevated liver enzymes along with a two times-daily pill, danuglipron, on account of robust Unwanted side effects—but CEO Albert Bou